INZY
Price
$2.93
Change
-$0.08 (-2.66%)
Updated
Dec 24 closing price
85 days until earnings call
PLRX
Price
$13.49
Change
+$0.15 (+1.12%)
Updated
Dec 24, 02:00 PM (EDT)
70 days until earnings call
Ad is loading...

INZY vs PLRX

Header iconINZY vs PLRX Comparison
Open Charts INZY vs PLRXBanner chart's image
Inozyme Pharma
Price$2.93
Change-$0.08 (-2.66%)
Volume$292.59K
CapitalizationN/A
Pliant Therapeutics
Price$13.49
Change+$0.15 (+1.12%)
Volume$119.25K
CapitalizationN/A
INZY vs PLRX Comparison Chart
Loading...
INZY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PLRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
INZY vs. PLRX commentary
Dec 25, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is INZY is a Hold and PLRX is a Hold.

Ad is loading...
COMPARISON
Comparison
Dec 25, 2024
Stock price -- (INZY: $2.93 vs. PLRX: $13.49)
Brand notoriety: INZY and PLRX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: INZY: 50% vs. PLRX: 65%
Market capitalization -- INZY: $188.22M vs. PLRX: $820.92M
INZY [@Biotechnology] is valued at $188.22M. PLRX’s [@Biotechnology] market capitalization is $820.92M. The market cap for tickers in the [@Biotechnology] industry ranges from $385.62B to $0. The average market capitalization across the [@Biotechnology] industry is $2.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

INZY’s FA Score shows that 0 FA rating(s) are green whilePLRX’s FA Score has 0 green FA rating(s).

  • INZY’s FA Score: 0 green, 5 red.
  • PLRX’s FA Score: 0 green, 5 red.
According to our system of comparison, INZY is a better buy in the long-term than PLRX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

INZY’s TA Score shows that 4 TA indicator(s) are bullish while PLRX’s TA Score has 4 bullish TA indicator(s).

  • INZY’s TA Score: 4 bullish, 4 bearish.
  • PLRX’s TA Score: 4 bullish, 7 bearish.
According to our system of comparison, INZY is a better buy in the short-term than PLRX.

Price Growth

INZY (@Biotechnology) experienced а -0.34% price change this week, while PLRX (@Biotechnology) price change was -6.12% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.85%. For the same industry, the average monthly price growth was -1.81%, and the average quarterly price growth was +3.32%.

Reported Earning Dates

INZY is expected to report earnings on Mar 20, 2025.

PLRX is expected to report earnings on Mar 04, 2025.

Industries' Descriptions

@Biotechnology (-0.85% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PLRX($821M) has a higher market cap than INZY($188M). PLRX YTD gains are higher at: -26.339 vs. INZY (-31.221). INZY has higher annual earnings (EBITDA): -90.3M vs. PLRX (-197.04M). PLRX has more cash in the bank: 405M vs. INZY (132M). INZY has less debt than PLRX: INZY (46.8M) vs PLRX (60.2M). INZY (0) and PLRX (0) have equivalent revenues.
INZYPLRXINZY / PLRX
Capitalization188M821M23%
EBITDA-90.3M-197.04M46%
Gain YTD-31.221-26.339119%
P/E RatioN/AN/A-
Revenue00-
Total Cash132M405M33%
Total Debt46.8M60.2M78%
TECHNICAL ANALYSIS
Technical Analysis
INZYPLRX
RSI
ODDS (%)
Bullish Trend 1 day ago
90%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
88%
Bullish Trend 2 days ago
84%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 2 days ago
89%
MACD
ODDS (%)
Bullish Trend 1 day ago
85%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 2 days ago
87%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
86%
Bullish Trend 2 days ago
75%
Advances
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 8 days ago
77%
Declines
ODDS (%)
Bearish Trend 7 days ago
90%
Bearish Trend 5 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 2 days ago
88%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 7 days ago
71%
View a ticker or compare two or three
Ad is loading...
INZY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PLRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RPFFX10.650.11
+1.04%
Royce Premier Service
RYWCX39.340.39
+1.00%
Rydex S&P SmallCap 600 Pure Growth C
AQEAX15.060.13
+0.87%
Columbia Disciplined Core A
ABVYX17.160.13
+0.76%
AB Large Cap Value Advisor
EKGCX20.730.13
+0.63%
Allspring Special Global Small Cap C

INZY and

Correlation & Price change

A.I.dvisor indicates that over the last year, INZY has been loosely correlated with BEAM. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if INZY jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INZY
1D Price
Change %
INZY100%
-2.66%
BEAM - INZY
58%
Loosely correlated
+0.38%
NAUT - INZY
53%
Loosely correlated
+0.58%
ABOS - INZY
50%
Loosely correlated
+1.13%
DNLI - INZY
49%
Loosely correlated
+0.67%
PLRX - INZY
47%
Loosely correlated
+1.12%
More

PLRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, PLRX has been loosely correlated with NTLA. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if PLRX jumps, then NTLA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PLRX
1D Price
Change %
PLRX100%
+0.98%
NTLA - PLRX
52%
Loosely correlated
-0.66%
CRSP - PLRX
51%
Loosely correlated
-0.59%
RCKT - PLRX
50%
Loosely correlated
-1.12%
BEAM - PLRX
50%
Loosely correlated
-1.07%
PRME - PLRX
49%
Loosely correlated
-3.10%
More